Spotlight
Commentary
Cultural Corner
Psychiatric Practice
Series
News
Job Board
CME/CE
Partners
Editorial
Subscribe
Article
Figures for Interest Grows in Treatment of Mood Disorders by Classic Psychedelics
This is the extra table for "Interest Grows in Treatment of Mood Disorders by Classic Psychedelics."
Table. Registered Clinical Trials on ClinicalTrials.gov
Newsletter
Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.
Related Videos
Ketamine-Assisted Psychotherapy: Updates From the 2025 APA Annual Meeting
Beyond the Usual Psychedelic Suspects: What Psychiatrists Need to Know
Exciting Agents in the 2025 Mood Disorders Treatment Pipeline
Expansion of the Glutamaterigc Story: Clinical Trial Successes and Failures in the Mood Disorders Space
A Multitude of Advancements Over the Past 40 Years
Innovation and Failure in Developing New Psychiatric Treatments
Dennis S. Charney, MD, Discusses the Last 40 Years in Psychiatry and Shares his Hopes for the Future
MM120 Shows Rapid and Lasting Anxiety Reduction in Phase 3 Generalized Anxiety Disorder Trials
FDA Breakthrough Therapy Designation and the Future of MM120
MindMed's Phase 3 Trials of MM120 for Generalized Anxiety Disorder Underway
Related Content
